KOD compared with SERA: revenue, margins and what each company keeps, and the suppliers and customers both name

KODKodiak Sciences Inc.

Mkt capRevenueRevenue

SERASera Prognostics, Inc.

Mkt capRevenueRevenue

Compare

KODKodiak Sciences Inc.

SERASera Prognostics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

KODKodiak Sciences Inc.

98.95▲+1.36%· post 98.06· delayed

Mkt cap$6.1BRevenue—Revenue—

SERASera Prognostics, Inc.

1.97▼−3.43%· post 1.95· delayed

After hoursNov 3 '26delayed

Mkt cap$78.5MRevenue$30,000Q2 FY26Revenue$81,000FY25

Compare

After hoursNov 3 '26delayed

KODKodiak Sciences Inc.

SERASera Prognostics, Inc.

98.95▲+1.36%post 98.06delayed

Price

1.97▼−3.43%post 1.95delayed

$6.1B

Mkt cap

$78.5M

—

Revenue

$30,000Q2 FY26

—

Revenue

$81,000FY25

KOD98.95▲+1.36%vsSERA1.97▼−3.43%After hoursNov 3 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

KOD: latest quarter not drawable. SERA: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only KOD 1

—Lonzaunlistedsupplier

Shared 0

No shared counterparties.

Only SERA 1

ELVElevance Healthcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

KOD, solidSERA, dashed